Quantifying the population impact of a prophylactic Helicobacter pylori vaccine
- 3 December 2001
- Vol. 20 (5-6) , 879-885
- https://doi.org/10.1016/s0264-410x(01)00401-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Dynamic Transmission Model for Predicting Trends in Helicobacter pylori and Associated Diseases in the United StatesEmerging Infectious Diseases, 2000
- National, State, and Urban Area Vaccination Coverage Levels Among Children Aged 19-35 Months—United States, July 1996-June 1997JAMA, 1998
- Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancerAlimentary Pharmacology & Therapeutics, 1997
- Vaccines for the treatment and prevention of Helicobacter pylori infectionPublished by Springer Nature ,1996
- Long-Term Course and Consequences ofHelicobacter pylorigastritis Results of a 32-Year Follow-up StudyScandinavian Journal of Gastroenterology, 1996
- Prevention ofHelicobacter pyloriInfectionScandinavian Journal of Gastroenterology, 1996
- Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in miceGastroenterology, 1995
- NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer DiseaseJAMA, 1994
- The US temporal and geographic variations of diseases related to Helicobacter pylori.American Journal of Public Health, 1993
- I. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer diseaseJournal of Gastroenterology and Hepatology, 1991